Tuesday, November 24, 2009, 11:33pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

NMT Medical Inc. (NMTI)

 At 15:07 EST: 1.82 USD  Down 0.08 (4.21%)  
MORE ON NMTI
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
NMT Medical Inc. (NCM:NMTI) Delayed quote dataEdit
Last Trade: 1.82 USD
Trade Time: 3:07PM EST
Change: Down 0.08 (4.21%)
Prev Close: 1.90
Open: 1.80
Bid: 0.92 x 100
Ask: 2.78 x 100
1y Target Est: 3.00
Day's Range: 1.62 - 1.90
52wk Range: 0.52 - 2.87
Volume: 21,969
Avg Vol (3m): 24,769.7
Market Cap: 24.07M
P/E (ttm): N/A
EPS (ttm): -1.12
Div & Yield: N/A (N/A%)
NMT Medical Inc. (NMTI)
1d  5d  3m  6m  1y  2y  5y  max 
 Add NMTI to Portfolio   Download Data

HEADLINES
• NMT MEDICAL INC Financials
EDGAR Online Financials (Wed, Nov 11)
• NMT MEDICAL INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
• NMT Medical Inc., Q3 2009 Earnings Call Transcript
at Seeking Alpha (Thu, Oct 29)
• NMT MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Oct 29)
• NMT Medical Announces Third-Quarter 2009 Financial Results
Business Wire (Thu, Oct 29)
• Q3 2009 NMT Medical Earnings Release - Before Market Open
CCBN (Thu, Oct 29)
• NMT Medical to Release Third-Quarter 2009 Financial Results on October 29
Business Wire (Fri, Oct 9)
• NMT Medical to Accelerate CLOSURE I Data Analysis Timing
Business Wire (Wed, Sep 16)
• NMT MEDICAL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T
EDGAR Online (Tue, Aug 11)
• NMT MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 6)
More Headlines for NMTI...
ANALYST
EPS Est (next year) (Dec-09) : N/A
EPS Est (in 2 years) (Dec-10) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
NMT Medical, Inc., a medical technology company, designs, develops, manufactures, and markets implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive catheter-based procedures.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices